[Clinical characteristics of viral pneumonia in patients with chronic obstructive pulmonary disease]

Zhonghua Jie He He Hu Xi Za Zhi. 2021 Feb 12;44(2):88-95. doi: 10.3760/cma.j.cn112147-20200811-00889.
[Article in Chinese]

Abstract

Objective: To study the clinical and etiological characteristics of viral pneumonia in patients with chronic obstructive pulmonary disease(VP-COPD), and to identify the risk factors associated with poor prognosis. Methods: From August 1, 2017 to August 1, 2019, totally 235 patients in a general hospital in Beijing were prospectively enrolled in this research, and all patients were diagnosed with viral pneumonia by imaging and etiology. The patients were divided into VP-COPD group(n=60) and VP-nCOPD(viral pneumonia in non-COPD patients) group(n=175). Pathogen detection and clinical characteristics were compared between the two groups.Finally, the binomial logistic regression was used to explore the risk factors associated with severe VP-COPD. Results: Compared with the VP-nCOPD group, the VP-COPD group was older(76.5 vs 66.0 years, P=0.001), and the CURB-65 score(2 vs 1, P= 0.001) and the PSI score(111 vs 85, P<0.001) were higher at admission. Pseudomonas aeruginosa(χ²= 10.308, P= 0.001) and Staphylococcus aureus(χ²= 5.953, P=0.028) were the most common co-infection bacteria. In the VP-COPD group type Ⅱ respiratory failure was more common(23.3% vs 6.8%, P<0.001), the number of severely ill patients was larger(48.3% vs 30.3%, P=0.011), the length of hospital stay was longer(13 vs 8, P<0.001), and the mortality rate during hospitalization was higher(18.3% vs 7.4%, P=0.016) in the VP-nCOPD group. Multivariate analysis showed that the level of blood glucose(OR: 1.73, 95%CI: 1.22-2.44, P= 0.002) and pleural effusion(OR: 133.12, 95%CI: 7.57-2 340.36, P=0.001) were risk factors for severe VP-COPD patients. Conclusion: Viral pneumonia in patients with COPD tended to develop into severe cases and had a poor prognosis.

目的: 观察合并慢性阻塞性肺疾病(简称慢阻肺)的病毒性肺炎(VP-COPD)患者的临床特征及病原学特点,探讨不良预后相关的风险因素。 方法: 前瞻性纳入2017年8月1日至2019年8月1日在北京同仁医院确诊的235例成人病毒性肺炎住院患者,根据是否合并慢阻肺分为VP-COPD组和未合并慢阻肺的病毒性肺炎组(VP-nCOPD组)。VP-COPD组60例,其中男49例,女11例,中位年龄76.5岁;VP-nCOPD组175例,男93例,女82例,中位年龄66.0岁。对两组患者进行病原体检测并比较临床特征,通过二项logistic回归探索重症VP-COPD的风险因素。 结果: VP-COPD组与VP-nCOPD组比较,年龄(76.5岁比66.0岁,P=0.001)、入院时CURB-65评分(2分比1分, P=0.001)和PSI评分(111 分比85分, P<0.001)差异均有统计学意义。VP-COPD组更易合并铜绿假单胞菌(χ²=10.308,P=0.001)及金黄色葡萄球菌(χ²=5.953,P=0.028)感染,Ⅱ型呼吸衰竭更常见(23.3%比6.8%,P<0.001),重症患者比例高(48.3%比30.3%,P=0.011),住院时间更长(13 d比8 d,P<0.001),院内病死率高(18.3%比7.4%,P=0.016)。多因素分析结果表明高血糖(OR值为1.73,95%CI:1.22~2.44,P=0.002)与胸腔积液(OR值为133.12,95%CI:7.57~2 340.36,P=0.001)是VP-COPD患者发展为重症的风险因素。 结论: 存在慢阻肺基础疾病的病毒性肺炎患者易发展为重症,预后不良,临床应予以重视。.

MeSH terms

  • Aged
  • China / epidemiology
  • Coinfection
  • Female
  • Humans
  • Length of Stay / statistics & numerical data
  • Male
  • Middle Aged
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / etiology*
  • Pneumonia, Viral / therapy
  • Prognosis
  • Pseudomonas Infections / epidemiology
  • Pseudomonas aeruginosa / isolation & purification
  • Pulmonary Disease, Chronic Obstructive / complications*
  • Pulmonary Disease, Chronic Obstructive / epidemiology
  • Pulmonary Disease, Chronic Obstructive / therapy
  • Respiration, Artificial / statistics & numerical data
  • Respiratory Insufficiency
  • Retrospective Studies
  • Risk Factors
  • Staphylococcal Infections / epidemiology
  • Staphylococcus aureus / isolation & purification